Try Ageless review

Most providers here charge one price whatever dose you take. Try Ageless says the opposite on every GLP-1 page it sells: the exact price depends on the prescribed dose. On the semaglutide injection that is spelled out as a range across 0.25 to 2.5 mg, so a small dose sits at the cheap end instead of paying a full-dose rate. The catch is that you only learn your own figure after the clinical review, the headline on that page sits below the range printed further down it, and the tirzepatide injection page shows a single headline figure with no price per strength at all. The needle-free formats are real but cost more than the injection. It names both the pharmacy that dispenses, Pharmacy Hub in Miami, and the practice and physician who prescribe, which most providers here will not do. What is not good: there is no dedicated microdose product, no state list is published, its own figures for the same non-GLP-1 product disagree across its own pages, and the company that operates it has an FDA warning letter against it that has not been closed out. That letter is disclosed on this page and on every ranking that lists it; it is not a reason we delist anyone, and it is not ours to characterize.

Vs median

$50/mo below the $169 median across the 261 of 407 programs here that publish a plain monthly rate

Market

$59–$1,300/mo is the full published spread on this site

Structure

Quotes off the lowest dose

Consult

Included in the price

Dietitian

Not included

Labs

Optional

Pricing

Varies by dose, plan or tier

Try Ageless does not publicly identify the pharmacy that fills its prescriptions. Bloodwork is offered but not required. A clinician review is included in the price.

Try Ageless is a compounded telehealth storefront with an unusually broad menu: semaglutide as a weekly injection, sublingual drops or a troche, tirzepatide as a weekly injection or sublingual drops, alongside sermorelin, NAD+, methylene blue, MIC+B12, naltrexone and testosterone. It is 100% online: a licensed clinician reviews an intake before anything is prescribed, and no insurance is involved. What matters most on a low-dose site is how it prices: every GLP-1 product page gives a price range across its strengths and says the exact amount depends on the prescribed dose. The semaglutide injection runs $119 to $229 for a month's supply across 0.25 to 2.5 mg, so a low dose is the cheaper end of the range rather than a full-dose price. The tirzepatide injection page shows only a $149 headline, with no price per strength. The catch is that you only learn your exact figure after clinical review, and the semaglutide headline ($99) sits below the range printed further down the same page. It names its dispensing pharmacy, Pharmacy Hub in Miami, and its prescribing practice, Wasef Health, PC under Michael Wasef, MD (NPI 1417261926). Everything compounded is not FDA-approved.

The exact price is shown only after clinical review, so the dose-based range is all you can cost in advance

• The semaglutide injection headline ($99) is lower than the bottom of the dose range printed on the same page ($119), and the tirzepatide injection page prints no price per strength at all
• The needle-free formats cost more than the injection: semaglutide drops start at $199 against $119 for the injection
• Its own figures for the same non-GLP-1 product disagree across its own pages: the sermorelin injection appears at $189, at $126, at $239–$289 and at $199–$299 depending on which page you read
• No state-availability list is published
• The LegitScript seal displayed on its own page does not render, so the certification the badge asserts cannot be checked from the badge itself
• Compounded semaglutide and tirzepatide are not FDA-approved and are not generic equivalents of Wegovy, Ozempic, Mounjaro or Zepbound, and intentional microdosing is off-label and unproven

Try Ageless is one of 407 low-dose GLP-1 programs compared on this site, and 261 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• Sublingual troches and drops
• What the evidence actually shows
• Is compounded GLP-1 safe?
• Microdose & reconstitution calculator
• The true annual cost of a plan